Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma. | Exp Hematol Oncol | 2022 | 36243813 | PubTator, text mining | PubMed |
| CRISPR/Cas systems usher in a new era of disease treatment and diagnosis. | Mol Biomed | 2022 | 36239875 | PubTator, text mining | PubMed |
| scATACpipe: A nextflow pipeline for comprehensive and reproducible analyses of single cell ATAC-seq data. | Front Cell Dev Biol | 2022 | 36238687 | PubTator, text mining | PubMed |
| Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy. | Int J Mol Sci | 2022 | 36232698 | PubTator, text mining | PubMed |
| Krüppel-Like Factor 1: A Pivotal Gene Regulator in Erythropoiesis. | Cells | 2022 | 36231031 | PubTator, text mining | PubMed |
| Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer. | Cells | 2022 | 36230990 | PubTator, text mining | PubMed |
| CircKIF4A Is a Prognostic Factor and Modulator of Natural Killer/T-Cell Lymphoma Progression. | Cancers (Basel) | 2022 | 36230873 | PubTator, text mining | PubMed |
| The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives. | Cancers (Basel) | 2022 | 36230686 | PubTator, text mining | PubMed |
| Alzheimer's disease large-scale gene expression portrait identifies exercise as the top theoretical treatment. | Sci Rep | 2022 | 36229643 | PubTator, text mining | PubMed |
| Metabolite-derived protein modifications modulating oncogenic signaling. | Front Oncol | 2022 | 36226054 | PubTator, text mining | PubMed |
| Activation of γ-globin expression by hypoxia-inducible factor 1α. | Nature | 2022 | 36224385 | PubTator, text mining | PubMed |
| Ex vivo exposures to arsenite and its methylated trivalent metabolites alter gene transcription in mouse sperm cells. | Toxicol Appl Pharmacol | 2022 | 36209798 | PubTator, text mining | PubMed |
| TBL1X: At the crossroads of transcriptional and posttranscriptional regulation. | Exp Hematol | 2022 | 36206873 | PubTator, text mining | PubMed |
| Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells. | Cell Stem Cell | 2022 | 36206730 | PubTator, text mining | PubMed |
| Functional inference of gene regulation using single-cell multi-omics. | Cell Genom | 2022 | 36204155 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials. | Signal Transduct Target Ther | 2022 | 36198685 | PubTator, text mining | PubMed |
| The DNA repair function of BCL11A suppresses senescence and promotes continued proliferation of triple-negative breast cancer cells. | NAR Cancer | 2022 | 36186110 | PubTator, text mining | PubMed |
| MicroRNA-92a-3p-mediated inhibition of BCL11A upregulates γ-globin expression and inhibits oxidative stress and apoptosis in erythroid precursor cells. | Hematology | 2022 | 36178486 | PubTator, text mining | PubMed |
| Fetal hemoglobin-boosting haplotypes of BCL11A gene and HBS1L-MYB intergenic region in the prediction of clinical and hematological outcomes in a cohort of children with sickle cell anemia. | J Hum Genet | 2022 | 36167770 | PubTator, text mining | PubMed |
| Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease. | Front Med (Lausanne) | 2022 | 36160143 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=32